Novo Nordisk cuts forecasts after replica obesity drugs hit US take-up
‘Compounded’ drugs custom made by pharmacies appeared after US regulator declared shortages in 2022
You are not logged in so some information on this page has been withheld. To see more, please log in.
since
auto-detected in 26 stories
28 days ago
page 1 of 1